1. Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors. (September 2013) Authors: Rydén, Anna; Denison, Hans; Karlsson, Maria; Vakil, Nimish Journal: Scandinavian journal of gastroenterology Issue: Volume 48:Number 9(2013) Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors. (September 2013) Authors: Rydén, Anna; Denison, Hans; Karlsson, Maria; Vakil, Nimish Journal: Scandinavian journal of gastroenterology Issue: Volume 48:Number 9(2013) Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of trismus on health‐related quality of life and mental health. Issue 11 (27th January 2015) Authors: Johnson, Joakim; Johansson, Mia; Rydén, Anna; Houltz, Erik; Finizia, Caterina Journal: Head & neck Issue: Volume 37:Issue 11(2015:Nov.) Page Start: 1672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Living with heart failure: patient experiences and implications for physical activity and daily living. (26th January 2022) Authors: Niklasson, Anna; Maher, Joshua; Patil, Rakshit; Sillén, Henrik; Chen, Jersey; Gwaltney, Chad; Rydén, Anna Journal: ESC heart failure Issue: Volume 9:Number 2(2022) Page Start: 1206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer. (January 2020) Authors: Leighl, Natasha B.; Karaseva, Nina; Nakagawa, Kazuhiko; Cho, Byoung-Chul; Gray, Jhanelle E.; Hovey, Tina; Walding, Andrew; Rydén, Anna; Novello, Silvia Journal: European journal of cancer Issue: Volume 125(2020) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study. Issue 12 (December 2019) Authors: Hui, Rina; Özgüroğlu, Mustafa; Villegas, Augusto; Daniel, Davey; Vicente, David; Murakami, Shuji; Yokoi, Takashi; Chiappori, Alberto; Lee, Ki Hyeong; de Wit, Maike; Cho, Byoung Chul; Gray, Jhanelle E; Rydén, Anna; Viviers, Louis; Poole, Lynne; Zhang, Yiduo; Dennis, Phillip A; Antonia, Scott J Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported symptoms possibly related to treatment with osimertinib or chemotherapy for advanced non-small cell lung cancer. (August 2018) Authors: Sebastian, Martin; Rydén, Anna; Walding, Andrew; Papadimitrakopoulou, Vassiliki Journal: Lung cancer Issue: Volume 122(2018) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream. (July 2017) Authors: Reaney, Matthew; McHorney, Colleen A.; Curtis, Bradley; Rydén, Anna; Chassany, Olivier; Gwaltney, Chad Journal: Therapeutic innovation & regulatory science Issue: Volume 51:Number 4(2017:Jul.) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗